SEARCH

SEARCH BY CITATION

References

  • 1
    Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J Natl Cancer Inst 2009; 101: 13251329
  • 2
    Jang TL, Yossepowitch O, Bianco FJ Jr, Scardino PT. Low risk prostate cancer in men under age 65: the case for definitive treatment. Urol Oncol 2007; 25: 510514
  • 3
    Merrick GS, Wallner KE, Butler WM et al. Brachytherapy in men aged < or = 54 years with clinically localized prostate cancer. BJU Int 2006; 98: 324328
  • 4
    Gomez-Iturriaga Pina A, Crook J, Borg J, Lockwood G, Fleschner N. Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged<or=55 years with favorable prostate cancer. Urology 2010; 75: 14121416
  • 5
    Burri RJ, Ho AY, Forsythe K, Cesaretti JA, Stone NN, Stock RG. Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010; 77: 13151321
  • 6
    Khan MA, Han M, Partin AW, Epstein JI, Walsh PC. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology 2003; 62: 8691; discussion 91–2
  • 7
    Zelefsky MJ, Marion C, Fuks Z, Leibel SA. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy. J Urol 2003; 170: 18281832
  • 8
    Yamada Y, Bhatia S, Zaider M et al. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 2006; 5: 157164
  • 9
    Zelefsky MJ, Yamada Y, Cohen GN et al. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications. Radiother Oncol 2007; 84: 185189
  • 10
    Zelefsky MJ, Yamada Y, Marion C et al. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 2003; 55: 956963
  • 11
    Albertsen PC, Hanley JA, Penson DF, Barrows G, Fine J. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort. J Urol 2007; 177: 932936
  • 12
    Stock RG, Stone NN, Cesaretti JA, Rosenstein BS. Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys 2006; 64: 527533
  • 13
    Rosser CJ, Kamat AM, Wang X et al. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with radical prostatectomy. Urology 2006; 67: 769773
  • 14
    Rosser CJ, Chichakli R, Levy LB, Kuban DA, Smith LG, Pisters LL. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation. J Urol 2002; 168: 536541
  • 15
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Adamovich E. Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer. Urology 2004; 64: 754759
  • 16
    Shapiro EY, Rais-Bahrami S, Morgenstern C, Napolitano B, Richstone L, Potters L. Long-term outcomes in younger men following permanent prostate brachytherapy. J Urol 2009; 181: 16651671; discussion 1671
  • 17
    Pina AG, Crook JM, Kwan P, Borg J, Ma C. The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapy. Brachytherapy 2010; 9: 213218
  • 18
    Gomez-Iturriaga Pina A, Crook J, Borg J, Lockwood G, Fleshner N. Median 5 year follow-up of 125 iodine brachytherapy as monotherapy in men aged < or= 55 years with favorable prostate cancer. Urology 2010; 75: 14121416
  • 19
    Stock RG, Kao J, Stone NN. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 2001; 165: 436439
  • 20
    Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005; 17: 307319
  • 21
    Johannes CB, Araujo AB, Feldman HA, Feldman HA, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460463